Epistaxis or epiphora as a sign for extension of a conjunctival melanoma. A series of six patients with nasolacrimal recurrence

Br J Ophthalmol. 2010 Oct;94(10):1328-31. doi: 10.1136/bjo.2009.168823. Epub 2010 Jun 27.

Abstract

Purpose: To characterise malignant conjunctival melanomas with extension and recurrence in the nasolacrimal system.

Methods: Localisation of the primary tumour and recurrences of 210 conjunctival melanomas treated in The Netherlands were reviewed for orbital and nasal tumours (1978-2008). Based of these cases and literature data, characteristics for nasolacrimal system extension and metastasis were reviewed.

Results: Six patients (3%) showed a recurrence of the primary conjunctival melanoma in the nasolacrimal system. Two of the six primary tumours were limbal tumours; the other four were diffuse tumours involving the fornix. In all six patients, the primary conjunctival melanomas were associated with primary acquired melanosis. During the follow-up period (11.6±3 years, range 3.4-28.5 years, median 8.7 years) two patients developed metastases and died.

Conclusions: Patients should be advised to contact their treating ophthalmologist in the case of symptoms of epiphora, nose obstructions and epistaxis, especially non-bulbar and diffuse cases associated with primary acquired melanosis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Conjunctival Neoplasms*
  • Epistaxis / etiology*
  • Eye Neoplasms / secondary*
  • Fatal Outcome
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Lacrimal Apparatus Diseases / etiology*
  • Male
  • Melanoma / secondary*
  • Middle Aged
  • Nasolacrimal Duct*
  • Recurrence